A B S T R A C T Two distinct lipoprotein receptors can be expressed in the dog liver. One is the apolipoprotein (apo-) B,E receptor. This receptor binds apo-B-containing low density lipoproteins (LDL), as well as apo-E-containing lipoproteins, such as the cholesterol-induced high density lipoproteins (HDL,). The second hepatic lipoprotein receptor is the apo-E receptor. It binds apo-E HDLC and chylomicron remnants, but not LDL. The present studies were undertaken to determine whether short-term (acute) regulation of the two receptors can occur in response to perturbations in hepatic cholesterol metabolism. The design used three groups of experimental animals: (a) immature dogs (with both hepatic apo-B,E and apo-E receptors expressed), (b) adult dogs (with predominantly the apo-E receptor expressed and little detectable apo-B,E receptor binding activity), and (c) dogs treated with the bile acid sequestrant cholestyramine or those that have undergone biliary diversion (with apo-E receptors and induced apo-B,E receptors).
per kg) or saline were infused intravenously for 6-8 h into matched pairs of dogs. Serial liver biopsies were obtained at intervals of 1-2 h. A progressive loss of specific (calcium-dependent) binding of LDL was seen in hepatic membranes from both immature and cholestyramine-treated dogs. After 4-6 h of lymph infusion, almost no apo-B,E receptor binding could be detected. The decrease in binding of apo-E HDLC to the same membranes was much less pronounced, and could be explained by a loss of binding of HDLC to the apo-B,E receptor; there was little or no effect on apo-E receptor binding.
In the second series of experiments, the effects of a diminished hepatic demand for cholesterol on lipoprotein receptor expression were studied by suppressing bile acid synthesis. The bile acid taurocholate (2-3 jmol/kg per min) was infused intravenously over a 6-h interval. This resulted in a progressive loss of LDL binding to liver membranes of immature or cholestyramine-treated dogs. The infusion of taurocholate for 6 h did not significantly alter the expression of the apo-E receptor binding activity, whereas apo-B,E receptor activity was rapidly down-regulated. Preparation of a bile fistula in adult dogs markedly induced the expression of the apo-B,E receptor. In this state, the binding activity of the apo-B,E receptor could be almost totally abolished by reinfusion of taurocholate for 6 h, without profoundly affecting apo-E receptor binding. Evidence from the analysis of plasma lipoprotein patterns and tissue culture reactivity suggested that changes in assayed hepatic lipoprotein receptor activity occurred in concert with changes in plasma lipoproteins.
INTRODUCTION
The liver is a key organ in cholesterol and lipoprotein homeostasis (1, 2) . It both synthesizes cholesterol and acquires cholesterol from chylomicron remnants and other lipoproteins. Hepatic cholesterol, regardless of its origin, can be resecreted into the plasma in endogenous lipoproteins or into the bile as free cholesterol or, after conversion, as bile acids. Biliary excretion is the dominant pathway for net removal of cholesterol from the body.
Present knowledge supports the concept that most excreted cholesterol and bile acids are derived from plasma lipoprotein cholesterol (for review see 1) . The first step in the hepatic uptake of lipoprotein cholesterol is the binding of plasma lipoproteins to liver membrane receptors (2) . Knowledge of the possible regulation of lipoprotein uptake by modulation of liver receptor activity is thus of major importance in understanding how body cholesterol and lipoproteins are metabolized. Moreover, nonreceptor-mediated uptake of lipoproteins may also be of significance in total body cholesterol metabolism (for review see 3) .
Recent studies of canine liver have demonstrated the presence of two distinct types of high affinity receptors that interact with plasma lipoproteins (4, 5) . One of the hepatic receptors is the low density lipoprotein (LDL) or apolipoprotein (apo-)' B,E receptor, which interacts with both apo-B-containing LDL and apo-E-containing high density lipoproteins (HDL), such as cholesterol-induced apo-E HDLC. Normally, this receptor is not readily detectable, or is expressed at low levels with controlled metabolic conditions, in the livers of mature, adult dogs (>18 mo of age). However, the hepatic apo-B,E (LDL) receptors can easily be demonstrated (expressed at high levels) in immature, growing animals. Likewise, these receptors can be induced to high levels in adult dogs that have been treated with the bile acid sequestrant cholestyramine or subjected to prolonged fasting (4, 5) . The apo-B,E ' Abbreviations used in this paper: apo, apolipoprotein; apo-E HDLC, cholesterol-induced high density lipoproteins containing only apo-E; CHAPS, 3[(3-cholamidopropyl) receptor closely resembles the LDL receptor in fibroblasts (4) (5) (6) (7) . The second hepatic receptor, the apo-E receptor, is present on liver membranes of both adult and immature dogs. It differs from the apo-B,E receptor in that it binds apo-E-containing lipoproteins but does not interact with normal LDL. This receptor is presumably responsible for the high affinity uptake of chylomicron remnants by the liver (5, (8) (9) (10) (11) . It has been identified in liver membranes not only from dogs, but also from swine and man (4, 5) .
Previous studies have indicated that the activity of the canine hepatic apo-B,E receptor can be regulated by long-term metabolic perturbations (4, 5) . Feeding of the hypocholesterolemic drug cholestyramine or long-term fasting resulted in an increased expression of the apo-B,E receptor in adult dogs. On the other hand, feeding immature dogs a diet high in cholesterol and saturated fat led to the loss of apo-B,E receptor binding activity. In the present study, we have investigated whether the binding activity of the apo-B,E and/or the apo-E receptors in dog liver membranes can be influenced by induced short-term changes in liver cholesterol metabolism. We studied immature dogs (with both receptors initially expressed), adult dogs (with predominantly apo-E receptors), and dogs treated with cholestyramine (with apo-E receptors and induced apo-B,E receptors). These studies were carried out under two principal protocols: (a) infusion of lymph (resulting in an increased load of exogenous cholesterol delivered to the liver), and (b) infusion of bile acids (resulting in a reduced conversion of cholesterol to bile acids). The results indicate that shortterm regulation of the binding activity of the apo-B,E receptor, but not of the apo-E receptor, occurs in dog liver membranes. METHODS Animals. Mature (>1.5 yr of age) and immature (<0.5 yr of age) foxhounds were obtained from Brink Farm (Paola, KS). The animals had continuous access to water and were fed a normal dog chow diet (Purina Dog Meal, Ralston Purina Co., St. Louis, MO). Six dogs, 6-8-mo-old, were treated with cholestyramine (Colestipol hydrochloride, kindly provided by Douglas McCarter of the Upjohn Co., Kalamazoo, MI) at a dose of 35 g (2-3 g/kg of body wt) for at least 10 d before being studied. The cholestyramine was mixed with the dog food (Kal Kan Chunky Meat Stew). In three mature foxhounds, cholecystectomy was performed, and a T-tube with an occludable balloon (Baldwin balloon occlusion Ttube, 10F, C. R. Bard International Inc., Murray Hill, NJ) was inserted into the common bile duct while the animals were under halothane anesthesia. The external limb of the T-tube was occluded and the balloon deflated, so that the normal enterohepatic circulation was maintained for 5 wk. This was done to establish postoperative stabilization. Total biliary diversion was established 5 d before the infusion studies. While the foxhounds were under local anesthesia, the external limb of the T-tube was opened, and the occlusion balloon in the distal limb was inflated, creating a total bile fistula. Basal data on the animals used for the various infusion experiments are given in Table I .
Lipoprotein isolation. All dogs were fasted overnight before blood sampling. Canine LDL were isolated from the plasma of foxhounds fed the commercial dog chow. The apo-E HDLC were prepared from the plasma of foxhounds fed a semisynthetic diet containing 5% cholesterol and 16% hydrogenated coconut oil (12) . The LDL were isolated by ultracentrifugation (d = 1.02-1.063) in a 60-Ti rotor (Beckman Instruments, Inc., Mountain View, CA) at 59,000 rpm for 18 h and were purified by Geon-Pevikon block electrophoresis (13) . The Isolated LDL contained apo-B as the only detectable band on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and migrated as a single band with a-mobility on paper electrophoresis. The apo-E HDLC were isolated by Geon-Pevikon electrophoresis from the ultracentrifugal fraction, d= 1.006-1.02, as described (12) and mainly, or exclusively, contained apo-E as demonstrated by gel electrophoresis. The isolated lipoproteins were dialyzed extensively against 0.15 M NaCl, 0.01% EDTA, pH 7.0, before use. Canine '251-apo-E HDL, were iodinated by the Bolton-Hunter procedure, as described previously (14) . The '25I-LDL were prepared according to the method of Bilheimer et al. (15) . The specific activities of "5I-apo-E HDLC were generally 500-800 cpm/ng of protein, and those of 125I-LDL were 250-500 cpm/ng. Lymph collection. Lymph fistulas were created in mongrel dogs (15-20 kg) anesthetized with halothane, by using a modification of the procedure of Rajpal and Kirkpatrick (16), as previously described (17) . The dogs were fed meat dog food (Kal Kan Chunky Meat Stew), and lymph was collected into 600-ml Fenwal blood packs (Baxter Travenol Laboratories, Travenol Laboratories, Inc., Deerfield, IL) containing disodium-EDTA (final concentration, 1 mg/ml). Lymph was generally collected for [2] [3] d, stored at 4°C under sterile conditions, and used for infusion studies within 5 d of collection. The mean triglyceride and cholesterol concentrations of the lymph preparations used in the different experiments were 3.2±0.5 (SEM) g/dl and 92±12 mg/dl, respectively. More than 90% of the cholesterol and more than 98% of the triglyceride were present in the d < 1.02 density fraction, as demonstrated by density-gradient ultracentrifugation according to the method of Redgrave et al. (18) . The major apoproteins of the d < 1.02 fraction, demonstrated by SDS-polyacrylamide gel electrophoresis, were apo-B, apo-A-I, apo-A-IV, and apo-E. The apo-B was almost exclusively of the low molecular weight form, similar to the B-48 described in man (19 (18) . The resulting top layer (chylomicron remnants) was removed and dialyzed against saline. This procedure resulted in the hydrolysis of 98% of the chylomicron triglycerides. The chylomicron remnants were iodinated by the Bolton-Hunter method (14) . The specific activity of the 1251 remnants was -1,700 cpm/ng of protein.
Experimental procedure. In general, pairs of littermates (one control and one experimental animal) were studied in each experiment (Table I) . Special attention was given to standardizing the preoperative care of the animals. They were housed at constant temperature and humidity with light cycling (dark 7 p.m. to 7 a.m.) for at least 4 d before the experiment (usually for several weeks). Food was given daily at 10 a.m., and the animals were deprived of food after 4 p.m. on the day before the experiment, which was started between 7 and 8 a.m. Induction of anesthesia was performed by an injection of sodium pentothal (25 mg/kg of body wt), whereafter the dogs were ventilated, and light anesthesia continued with methoxyflurane (Metofane, Pitman-Moore, Inc., Washington Crossing, NJ). Catheters were inserted into the femoral vein and artery, and an intravenous infusion of 0.15 M saline was given at a rate of 2.2-4.4 ml/min, with a Harvard Apparatus Co. (S. Natick, MA) infusion pump.
In addition, a slow infusion of lactate-Ringer solution with 10% dextrose was given via a cephalic vein. The abdomen was opened, and two base-line liver biopsies (3-4 g each) were obtained. Special care was given to taking paired samples from similar anatomical locations in the two dogs.
After obtaining the liver biopsies to establish base-line values, an infusion of lymph (5-11 mg of triglycerides, 0.15-0.30 mg of cholesterol/kg of body wt per min) or taurocholate (2-3 umol/kg per min, with a solution of -20 mM taurocholate in 0.15 M saline) was started in the experimental animal. The saline infusion was continued at a similar rate into the control dog. Liver biopsies were obtained at intervals of 1-2 h from both dogs for 6-8 h. Continuous monitoring of arterial pH, pco2, and P02 was performed in nine experiments by using a Corning model 175 blood gas analyzer (Corning Medical, Corning Glass Works, Medford, MA), and demonstrated stable conditions throughout the experiments.
Isolation of canine liver membranes. Liver membranes were prepared according to the procedure of Kovanen et al. (21) . The liver samples were immediately rinsed in ice-cold phosphate-buffered saline, and 1-2 g were suspended in 10-20 ml of 10 mM Tris-HCl, pH 7.5, 150 mM NaCI, 1.0 mM CaCl2, and 1.0 mM phenylmethylsulfonyl fluoride. All steps in the preparation were carried out at 4°C. The suspension was homogenized with four 15-s pulses in a Polytron homogenizer (Brinkmann Instruments, Inc., Westbury, NY; PT 30, setting 8), and the homogenates were centrifuged at 500 g for 5 min. The. supernatants were recentrifuged at 8,000 g for 15 min. The resulting supernatants were then centrifuged at 100,000 g for 60 min, and the pellets were washed once by recentrifugation at 100,000 g for 60 min in the above buffer. In some experiments, receptors were solubilized from membrane fragments as described by Schneider et (27) .
Analysis of plasma and liver lipids. Total plasma cholesterol and plasma triglyceride levels were determined by using enzymatic procedures (Bio-Dynamics, Boehringer Mannheim Corp., Indianapolis, IN). Cholesterol, free and esterified, and triglycerides in liver tissue homogenates were quantified by a combination of thin-layer chromatography and gas-liquid chromatography (Hewlett-Packard Co., Palo
Alto, CA; model 5880). Plasma concentrations of total bile acids were determined by using a 3a-steroid dehydrogenase assay (Sterognost-3a, Myegaard A/S, Oslo, Norway).
Plasma samples and LDL fractions were analyzed on polyacrylamide gradient gels (PAA4/30, Pharmacia Diagnostics, Div. of Pharmacia, Inc., Piscataway, NJ) and stained with Oil red 0 (28). Gels were run for 24 h at 12-140C. After staining, peaks were quantitated by microdensitometry.
Cultured fibroblast binding assay. Normal human fibroblasts, obtained and maintained as previously described (14) , were dissociated from stock flasks with 0.05% trypsin, 0.02% EDTA solution and plated in 35-mm petri dishes at a density of 3.5 X 104 cells per dish. 1 wk later, after the apo-B,E (LDL) receptors had been induced by a 48-h incubation of the cells with medium containing 10% lipoprotein-deficient serum, the cells were used for experiments. The binding assays were performed at 4°C as described (29) , except that the cells plated in the 35- Fig. 2 , the direct binding data obtained for the 1251-apo-E HDLC of a cholestyramine-treated dog during the preinfusion phase (basal control period) and after the period of saline infusion, were essentially identical. The maximum amount of apo-E HDLC 40 
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FIGURE 3 Calcium-dependent binding of 1251-LDL to liver membranes from a cholestryamine-treated dog (dog 9) before and after infusion of saline for 6 h. 6 h of lymph infusion, there was a reduction in the amount of apo-E HDLC bound to liver membranes (Fig. 4A) . The affinity of the binding did not change, but the maximum amount of apo-E HDL, bound decreased (in this example, from 42 to 28 ng/mg of protein) (Fig.  4B ). This decrease in the binding of apo-E HDLC could theoretically be explained by a reduction of the binding activity of the apo-B,E and/or apo-E receptors. Studies of LDL binding showed that after 6 h of lymph infusion, saturable, high affinity, calcium-dependent binding of LDL to the same liver membranes was no longer demonstrable (Fig. 5) . As previously described (30) , binding of LDL and apo-E HDLC to the apo-B,E receptor occurs in a proportion of 3-4:1. By using this ratio, a reduction of 8-10 ng/mg in apo-E HDLC binding could be calculated to correspond to the loss of apo-B,E receptor binding activity in this experiment (31 ng/mg of protein). Thus, most, if not all, of the changes in apo-E HDLC binding induced by lymph infusion could be accounted for by a near total loss of detectable apo-B,E receptor binding activity.
The prompt, dramatic decrease in apo-B,E receptor binding activity that followed the infusion of lymph lipoproteins into the immature or cholestyraminetreated dogs is illustrated in Fig. 6 . The major reduction in LDL binding occurred between 2 and 4 h after the start of the lymph infusion. This rapid change in calcium-dependent LDL binding activity could be demonstrated repeatedly in both immature dogs and dogs treated with cholestyramine (Table II) , whereas apo-E HDLC binding activity was less dramatically affected by lymph infusion (Table III) . The results from all the experiments, using a given concentration Tables II and III . The results are expressed as the percentage of change in the activity based on the zero time (basal control) values. The mean reduction in binding of apo-E HDLC, compared with parallel control values after 6-7 h of lymph infusion, was 28±16%. By contrast, the corresponding reduction in LDL binding was 88±8%.
To determine more clearly whether or not the apo-E receptor was significantly down-regulated by the infusion of intestinal lipoproteins, the binding of apo-E HDLC to liver membranes from an adult dog (which expressed apo-E receptor binding activity and little detectable LDL binding) was measured during a 9-h infusion of lymph (Table I , dogs 11 and 12). Although high affinity LDL binding was not readily demonstrable (<1 ng of LDL protein bound/mg of hepatic membrane protein), calcium-dependent, saturable, high affinity binding of apo-E HDLC was virtually unchanged by the lymph infusion. With an apparent Kd of 0.13 X 10i M, the maximum amount of apo-E HDLC bound before lymph infusion was 37 ng of HDLC protein/mg of hepatic membrane protein, and 35 ng of HDLC protein/mg at the end of the 9 h of lymph infusion. Infusion of saline into an adult dog had no effect on the binding of apo-E HDLc.
Chylomicron remnants are presumed to bind to both the apo-B,E and apo-E receptors. Results from the present study demonstrated that '25I-labeled chylomicron remnants do in fact bind to both receptors. Even after a 6-h infusion of lymph, membranes from Infusion rime (Hours) a cholestyramine-treated dog bound chylomicron remnants with high affinity (Fig. 7) . The degree of reduction in maximum binding observed after suppression of apo-B,E receptor binding activity was in reasonable agreement with that seen for apo-E HDLC by using membranes from the same dog (Fig. 4B) . There was no change in the binding of chylomicron remnants to the liver membranes during saline infusion (data not shown).
The results thus far obtained indicated that the binding activity of the hepatic apo-B,E receptor, but not the apo-E receptor, was rapidly reduced by a plasma infusion of intestinal lipoprotein cholesterol and triglycerides. These observations were further tested by considering the effects of bile acid infusion on the regulation of the hepatic lipoprotein receptors. The biosynthesis of bile acids is regulated by the amount of bile acids returning to the liver (negative feedback) (31) . Suppression of bile acid formation would therefore considerably reduce the hepatic demand for cholesterol. Consequently, we investigated whether canine hepatic lipoprotein receptors were affected by the infusion of exogenous taurocholate, the major endogenous bile acid in the dog (32) (33) (34) .
When taurocholate was infused at a rate of 3.2
,umol/kg per min for 6 h into an immature dog, the calcium-dependent binding of apo-E HDLC was reduced by -50%, whereas the affinity of the binding remained unchanged (Fig. 8A) Lipoprotein Bound (ng/mg Protein) FIGURE 7 Scatchard plot of calcium-dependent binding of chylomicron remnants to liver membranes from a cholestyramine-treated dog (dog 10) before and after infusion of lymph for 6 h. Binding studies were performed at 230C with '251-labeled dog chylomicron remnants. X 10-M) in the presence of calcium (Fig. 8B) . After 6 h of taurocholate infusion, this binding was almost totally abolished (Fig. 8B) . The change in maximum binding of apo-E HDLC could thus be explained by the disappearance of apo-B,E receptor binding activity, whereas the binding activity of the apo-E receptor appeared to be relatively unaffected. In agreement with the results obtained in the lymph infusion studies, the binding of chylomicron remnants was reduced to the same extent as was that of apo-E HDLC (Fig. 8C) . There was no change in the binding activity of any of the three lipoproteins (apo-E HDLC, LDL, and chylomicron remnants) during saline infusion in the parallel control dog (data not shown).
A rapid reduction in LDL binding activity after taurocholate infusion was confirmed in three immature dogs, as well as in a cholestyramine-treated dog (Table  IV) . The changes in apo-E HDLC binding were much less pronounced (Table V) . The binding activities of the LDL and apo-E HDLC were compared by using a LDL concentration of 4.2-7.3 ,g/ml and an apo-E HDLC concentration of 0.2-0.6 ,g/ml in the binding assays. The mean relative reduction at 6 h, compared with the matched saline-infused controls, was 69±16% for LDL binding, and only 20±15% for apo-E HDLC binding.
The marked reduction in apo-B,E receptor binding to LDL observed in the membrane binding assay of the cholestyramine-treated dog (Table I, dog 20) was also observed in the solubilized liver membrane binding assay for the same dog (Table VI) . The LDL binding was reduced from 303 to 19 ng/mg of solubilized liver membrane protein by taurocholate infusion (3 ,umol/kg per min). These results, obtained with the solubilized receptor assay, suggested that the decrease in apo-B,E receptor activity, as determined by the membrane binding assay, was not due simply to a masking of receptor binding sites on the membranes.
In order to characterize further the possible role of bile acids as regulators of hepatic membrane apo-B,E receptor binding activity, total bile fistulae were created in three adult dogs. While the dogs were under general anesthesia, a liver biopsy (basal) was obtained, and an occludable T-tube was inserted into the common bile duct after cholecystectomy (as described in Methods). 5 wk after the operation, the distal limb of the T-tube was occluded, thus creating a total bile fistula. After biliary drainage for 5 d, each dog was anesthetized, a base-line liver biopsy was obtained (referred to as a bile fistula sample), and an infusion of taurocholate (3 umol/kg per min) was given for 6 h (Table I, The interruption of the enterohepatic circulation of the bile acids by the fistula induced apo-B,E receptor binding activity, as evidenced by high affinity, calcium-dependent binding of LDL to liver membranes (Table VII) . There was also a clear increase in the binding of apo-E HDLC, most of which could be accounted for by the binding of HDLC to the apo-B,E receptors. However, some increase in the binding activity of the apo-E receptor cannot be excluded. The reinfusion of taurocholate, which presumably suppressed the bile acid biosynthesis induced by the bile fistula, resulted in a marked reduction of LDL binding and a return of apo-E HDLC binding to initial levels (Table VII) . Similar changes were observed with solubilized membrane receptors (Table VIII) . Thus, stimulation of bile acid formation was associated with the induction of apo-B,E receptor binding activity, and suppression of bile acid biosynthesis resulted in rapid reduction in this activity.
It could be argued that the suppressive action of taurocholate was due to a less specific action of the bile acid on hepatic plasma membranes, e.g., the bile acids exerting a detergent effect on the cell surface receptors. However, such an effect would have had to be directed only against the apo-B,E receptors, because binding to the apo-E receptor was still observed. In order to test this possibility, we studied the effect of taurocholate on LDL binding activity in a cultured fibroblast system. When taurocholate, at concentrations of up to 1.5 mM, was incubated for 16 Finally, the relative insensitivity of the apo-E receptor to acute regulation by bile acid infusion was studied in adult dogs expressing predominantly the hepatic apo-E receptor. Liver membranes from dog 22 bound apo-E HDLC with an apparent Kd of 0.3 x 10-M both before and after 6 h of taurocholate infusion. The maximum amount of apo-E HDLC bound was 23 ng/mg of protein before the infusion and 22 ng/mg of protein at the end of the infusion. Similar results were obtained when binding to solubilized membrane receptors was determined in two additional adult dogs (Table IX) .
Thus, the binding activity of the apo-B,E receptors in dog liver membranes appears to be subject to rapid regulation in response to changes in the hepatic de- The assay of LDL was performed as described in Methods by using a constant concentration of membrane protein (100-200 Mg) and labeled lipoprotein (4.2-7.3 gg/ml) within each experiment. 5 ,ug/ml in the bile acid-infused dog after 6 h, vs. 50% displacement of LDL at 20 ug/ml in the saline-infused control after 6 h. As shown in Fig. 9A , more detailed studies demonstrated a progressive increase with time in the bind- (Fig. 9B) . Furthermore, gradient gel electrophoresis of the plasma of the taurocholate-infused, bile fistula dog (dog 23) demonstrated a relative increase in the lipid staining of the LDL. As shown in Fig. 10 , microdensitometric scanning of the gel patterns revealed a significant change in LDL concentration, comparing the plasma sample taken immediately before the bile acid infusion with that obtained after 4 h of infusion. No change in the plasma lipoprotein distribution was observed in the taurocholate-infused adult dog (dog 24).
DISCUSSION
The present studies were performed to determine whether rapid regulation of the binding activity of hepatic lipoprotein receptors occurs in response to acute changes in hepatic cholesterol demand. The results show a marked difference in the metabolic regulation of the two receptors previously demonstrated on hepatic membranes, the apo-B,E receptor and the apo-E receptor. In response to two completely different perturbations of hepatic cholesterol metabolism, an excessive load of exogenous cholesterol in the form of lymph lipoproteins and an induced feedback inhibition of bile acid biosynthesis by the infusion of exogenous bile acids, there was a dramatic decrease in the binding activity of the apo-B,E receptors on canine hepatic membranes. On the other hand, the binding activity of the apo-E receptors on the same membranes was not significantly affected. These results from shortterm (acute) experiments are in accordance with prior observations from long-term experiments in which evidence was found for metabolic regulation of apo-B,E, but not for apo-E receptor binding activity (2, 4, 5) .
The significance of the hepatic, receptor-mediated uptake of apo-E-containing lipoproteins has been shown previously (4, 5, (8) (9) (10) (11) , and is further illustrated in the present studies. The importance of apo-E in the catabolism of chylomicron remnants is evident from observations of patients with type III hyperlipoproteinemia; such subjects have a specific variant form of apo-E (E2) (36) (37) (38) . This isoform does not bind normally to lipoprotein receptors (39) (40) (41) and, consequently, these subjects accumulate chylomicron remnants ((-very low density lipoproteins [,B-VLDL]) in their plasma despite normal amounts of apo-B in the remnants (42) . The importance of the apo-E receptor in the binding and subsequent uptake of chylomicron remnants by the liver can be inferred from at least two lines of evidence in the present study. First, the changes in the binding of chylomicron remnants to hepatic membranes followed very closely the pattern of binding of apo-E HDLC to the membranes, but not that of LDL (Figs. 4B, 5, 7, and 8 ). This implies that chylomicron remnants can bind to both apo-B,E and apo-E receptors. Second, in spite of a continued infusion of lymph chylomicrons over a time period when LDL binding was almost totally abolished (cf Fig. 6B) , there was no evidence of a progressive increase in plasma lipids, and hepatic lipids continued to increase (cf Fig. 1 ). This suggests that the apo-E receptor binding activity of canine hepatic membranes may handle a considerable load of lipoproteins of dietary origin. Accordingly, the adult dog, which predominantly expressed apo-E receptor binding activity, did not show a reduced capacity for clearing lymph chylomicrons. If we assume that all of the cholesterol of the infused lymph was taken up by the liver, it can be estimated that the apo-E receptor-mediated uptake cleared at least 1.5 g of cholesterol during a typical 6-h experiment.
It would be interesting to consider whether the rapid loss of apo-B,E receptor binding activity observed during lymph infusion is of importance under more physiological conditions. Feeding a diet rich in cholesterol and saturated fat to immature dogs has been shown to repress hepatic apo-B,E receptor binding activity almost completely within 30 d (5) . No information is presently available with regard to the effect of shorter periods of cholesterol feeding in the dog. However, hepatic LDL binding activity was reduced by -50% as soon as 2 d after the initiation of a cholesterol-rich diet in the rabbit (43) . It is reasonable to speculate that the ingestion of meals rich in cholesterol may affect the hepatic uptake of LDL by rapidly influencing the apo-B,E receptor. Differences in the extent of the regulation of apo-B,E receptors, as well as in the expression of apo-E receptors, among various species may thus provide an explanation to the known variability in the response to such diets. Further work is clearly needed to evaluate this possibility.
In agreement with previous studies (4-6), the present work demonstrates that an increased expression of hepatic apo-B,E receptors could be induced by conditions that stimulate the biosynthesis of bile acids, i.e., cholestyramine treatment and biliary diversion. These results indicate that the hepatic requirement for cholesterol to be used in the biosynthesis of bile acids is an important regulator of apo-B,E receptor activity in the liver. The total interruption of the enterohepatic circulation of bile acids, which results in maximal induction of bile acid biosynthesis (31) , was linked to a rapid and dramatic induction (within 5 d) of apo-B,E receptor expression on hepatic membranes. The binding activity of these receptors was almost totally abolished when enhanced bile acid biosynthesis was suppressed by infusing bile acids into the circulation. A similar marked and rapid decrease in apo-B,E receptor binding was achieved by infusing bile acids into cholestyramine-treated dogs, as well as into immature dogs (Table IV) . The infusion rate chosen was high enough to suppress bile acid biosynthesis almost totally, but still well below the maximum excretory capacity of the liver (32) (33) (34) .
The association between hepatic LDL uptake (apo-B,E receptor activity) and bile acid metabolism has considerable relevance to some recent observations in man. Cholestyramine treatment has been shown to reduce plasma LDL levels in individuals with heterozygous familial hypercholesterolemia by increasing the receptor-mediated elimination of LDL (44) . However, plasma LDL levels in patients with homozygous (receptor-negative) familial hypercholesterolemia are not lowered even by treatment with a total bile fistula (45) . In addition, suppression of bile acid biosynthesis in man, which occurs during treatment with the primary bile acid chenodeoxycholic acid (46, 47) , results in a slight, but significant, increase in plasma LDL levels (48, 49) .2 Chenodeoxycholic acid treatment in man is associated with decreased hepatic cholesterol synthesis (50), a reduced production rate of VLDL (51) (the precursor of human plasma LDL), and possibly a reduction in LDL catabolism. The data in the present study suggest that the increase in plasma LDL levels and a possible reduction in LDL catabolism may be related to the rapid and dramatic down-regulation of hepatic apo-B,E receptor activity after bile acid treatment.
A particularly significant finding in the present work was the observation that the reduction in apo-B,E receptor binding activity on dog liver membranes occurred so rapidly (i.e., within 2-4 h), in response to both lymph and bile acid infusion. The decrease in binding activity was not only detected with the membrane binding assay, but also with the solubilized membrane preparations. The reduction was apparently limited to the liver, as the binding of LDL to adrenal membranes was not changed by bile acid infusion. While the regulation of the hepatic apo-B,E (LDL) receptors appears to be controlled by the cellular need for cholesterol, these results indicate that different mechanisms may operate to control receptor expression in various tissues. For example, in fibroblasts, preincubation with LDL for -24 h is necessary to obtain substantial down-regulation of receptor binding activity. The decrease in LDL binding activity in fibroblasts is the consequence of reduced synthesis, and thus of a decrease in the apparent number of receptor molecules (52) . However, in some situations there may be a more rapid regulation of the activity of the fibroblast receptor (53) . The rapidity of the down-regulation of hepatic apo-B,E receptor activity (within 2-4 h) suggests that a mechanism independent of protein synthesis may be involved in modulating the expression of the hepatic apo-B,E receptors.
The mechanism responsible for the rapid loss of apo- B,E receptor binding activity on hepatic membranes cannot be determined from the present work; however, several possibilities should be considered. One interesting possibility is that the hepatic receptor is subject to rapid recycling, as has been demonstrated for the fibroblast receptor (54) . In cultured human fibroblasts, the LDL (apo-B,E) receptors recycle every 12-15 min, and inhibition of this process can lead to a rapid loss of cell surface binding activity without a change in the total number of receptors. For example, in one study the treatment of fibroblasts with the ionophore monensin, which prevents receptor recycling, resulted in a loss of 75% of the surface binding activity of LDL within 15 min, and of 90% within 60 min (55) . In the present study of hepatic apo-B,E receptors, intracellular structural or conformational modification, or accelerated degradation of the recycling receptors, which would prevent expression of the apo-B,E receptors, could explain the rapid down-regulation of these receptors. To test these possibilities, experiments using a suitable in vitro culture system would be necessary. Whatever the mechanism, however, the present study presents clear evidence that the apo-B,E binding activity can be rapidly modulated and that the two hepatic receptors, the apo-B,E and the apo-E receptors, behave differently in response to induced changes in hepatic cholesterol metabolism.
